Your browser doesn't support javascript.
loading
PAK4-targeted PROTACs in clear cell renal cell carcinoma: a two-for-one targeted and immune therapy?
Bakouny, Ziad; Braun, David A; Reznik, Ed; Hakimi, A Ari.
Affiliation
  • Bakouny Z; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA. Electronic address: elbakoz@mskcc.org.
  • Braun DA; Center of Molecular and Cellular Oncology, Yale Cancer Center, Yale School of Medicine, New Haven, CT, USA.
  • Reznik E; Computational Oncology, Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Hakimi AA; Urology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
EBioMedicine ; 105: 105218, 2024 Jul.
Article in En | MEDLINE | ID: mdl-38924842
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Carcinoma, Renal Cell / Molecular Targeted Therapy / Kidney Neoplasms Limits: Humans Language: En Journal: EBioMedicine Year: 2024 Document type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Carcinoma, Renal Cell / Molecular Targeted Therapy / Kidney Neoplasms Limits: Humans Language: En Journal: EBioMedicine Year: 2024 Document type: Article